AERO-007 Inhalation Solution

· AeroRx Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AERO-007 Inhalation Solution, covering 2025-08-01 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD [Phase 1, Phase 2]

See pricing